News
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
After experiencing high growth in the U.S. telehealth scene, Hims is taking its personalized obesity treatments ...
The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.
Investors are buying Hims & Hers Health ( HIMS 10.09%) stock hand over fist after the mail-order drugs company reported an earnings miss but a sales beat last night. But they're selling off shares of ...
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava ...
Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...
Hims & Hers Health continues to fire on all cylinders as a business. Click here to read why HIMS stock is a Buy.
Hims & Hers teams up with Novo Nordisk to bundle Wegovy into a $599/month telehealth care plan. Investors see Amazon-like potential as Hims scales affordable healthcare through platform-based ...
Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback